Combined chemotherapy (CT) and erlotinib (E) as a first-line treatment of EGFR-mutated (EGFR M) NSCLC.
Elizabeth Dudnik
No relevant relationships to disclose
Jean Lopategui
No relevant relationships to disclose
Myriam Chevarie-Davis
No relevant relationships to disclose
Ronald B. Natale
No relevant relationships to disclose